Khademi Farzad, Sahebkar Amirhossein
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Scientifica (Cairo). 2021 May 27;2021:5573345. doi: 10.1155/2021/5573345. eCollection 2021.
In recent years, antibiotic-resistant pathogens including penicillin-nonsusceptible (PNSP) have posed serious threats against human health. The aim of this meta-analysis was to investigate the prevalence of drug resistance particularly the incidence of PNSP strains in Iran.
A systematic search was done in national and international electronic databases using Persian and English keywords. Up until May 20, 2020, a total of 58 publications were detected as eligible articles based on the inclusion and exclusion criteria, and then the selected studies were enrolled for data extraction and meta-analysis according to the PRISMA guidelines.
A high rate of PNSP (46.9%) and multidrug-resistant (MDR) (45.3%) in our isolates were evident. Furthermore, total frequency resistance to other drugs in was as follows: erythromycin 41.1%, azithromycin 53.2%, tetracycline 39.9%, levofloxacin 1.7%, rifampin 1.2%, clindamycin 31.7%, vancomycin 1.7%, trimethoprim/sulfamethoxazole 63.9%, chloramphenicol 20%, ceftriaxone 10.9%, amoxicillin 30.5%, ciprofloxacin 8.3%, imipenem 6.1%, linezolid 0%, and cefotaxime 8.3%.
Although the overall prevalence of cephalosporin- and carbapenem-resistant was low, penicillin-resistant strains, especially PNSP, could become a significant challenge to the healthcare system in Iran. Hence, the prescription of penicillin as the first-choice antibiotic in the treatment of infections should be avoided.
近年来,包括对青霉素不敏感(PNSP)在内的耐药病原体对人类健康构成了严重威胁。本荟萃分析的目的是调查伊朗耐药性的流行情况,特别是PNSP菌株的发生率。
使用波斯语和英语关键词在国家和国际电子数据库中进行系统检索。截至2020年5月20日,根据纳入和排除标准,共检测到58篇符合条件的文章,然后根据PRISMA指南将选定的研究纳入数据提取和荟萃分析。
我们分离出的菌株中PNSP(46.9%)和多重耐药(MDR)(45.3%)的比例很高。此外,对其他药物的总耐药频率如下:红霉素41.1%,阿奇霉素53.2%,四环素39.9%,左氧氟沙星1.7%,利福平1.2%,克林霉素31.7%,万古霉素1.7%,甲氧苄啶/磺胺甲恶唑63.9%,氯霉素20%,头孢曲松10.9%阿莫西林30.5%,环丙沙星8.3%,亚胺培南6.1%,利奈唑胺0%,头孢噻肟8.3%。
虽然对头孢菌素和碳青霉烯耐药的总体流行率较低,但耐青霉素菌株,尤其是PNSP,可能会给伊朗的医疗系统带来重大挑战。因此,应避免将青霉素作为治疗感染的首选抗生素。